Triphasic oral contraceptives: review and comparison of various regimens
- 1 January 2002
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 77 (1) , 1-14
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Efficacy, cycle control, and safety of two triphasic oral contraceptives: CyclessaTM (desogestrel/ethinyl estradiol) and Ortho-Novum® 7/7/7 (norethindrone/ethinyl estradiol) a randomized clinical trialContraception, 2000
- Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 μg and 35 μg estrogen preparationsContraception, 1999
- Desogestrel, Norgestimate, and Gestodene: The Newer ProgestinsAnnals of Pharmacotherapy, 1995
- New progestogens in oral contraceptionContraception, 1994
- The new low dose oral contraceptivesJournal of Obstetrics and Gynaecology, 1994
- Comparative contraceptive efficacy and mechanism of action of the norgestimate‐containing triphasic oral contraceptiveActa Obstetricia et Gynecologica Scandinavica, 1992
- Triphasic combination of ethinyl estradiol and gestodene long-term clinical trialContraception, 1992
- Evaluation of the clinical performance of three triphasic oral contraceptives: A multicenter, randomized comparative trialAmerican Journal of Obstetrics and Gynecology, 1989
- Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptivesContraception, 1988
- Phasic approach to oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1987